Drugs / Oxymatrine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02202473 | ? → Feb 2014 | chronic hepatitis B virus infection | Southeast University, China | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oxymatrine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02202473 ↗ |
| Modality | Small molecule | — CHEMBL458337 ↗ |
| Route | Oral | “oxymatrine Capsules (Chia Tai Tianqing Pharmaceutical Group Co., Ltd) 200 mg, po, tid.” NCT02202473 ↗ |